PHVS: Pharvaris N.V.
Performance
PHVS +59.66%
Watchlist
Select an item
Summary
PHVS at a glance
PHVS returned +59.66% over the past year and +17.92% a year over five years. Its worst drop in that year was -28.62%, smaller than 60% of stocks on Redstone, and its Sharpe ratio of 1.07 beats 78% of stocks on Redstone. It pays no dividends.
Current Drawdown
-11.30%
Rolling Volatility
50.16%
Actions
Metrics
Risk Indicators
Alpha49.28%
Beta0.86x
Sharpe1.07
Sortino1.71
Omega1.20
Calmar2.08
Martin5.75
Profile
About PHVS
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks.
- Sector
- Health Care
- Market cap
- $2.4B
- Listed
- Feb 2021
- Employees
- 129
- Website
- pharvaris.com
Comparisons